Dr Wooton holds a PhD in Health Inequalities and an MSc in Accountancy and Finance and she is a globally experienced healthcare leader with over 35 years of cross-sector impact across clinical care, operational leadership, and international innovation. She has led some of Greater Manchester’s most ambitious and acclaimed pan regional programmes for cardio, renal and metabolic conditions and an obesity programme that directly underpinned the work to inform the national Trizepatide trials. She also led high-impact national digital health programmes that received formal awards for innovation and service transformation, demonstrating her ability to convert complexity into scalable, tech-enabled care. With deep credibility, commercial fluency, and a powerful purpose, she is now scaling a brand that brings precision, empowerment, and longevity to women everywhere, unlocking both life-changing outcomes and market-defining opportunity.